![David H. Peyton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David H. Peyton
Corporate Officer/Principal bij Portland State University
Actieve functies van David H. Peyton
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Portland State University | Corporate Officer/Principal | 30-10-2009 | - |
Loopbaan van David H. Peyton
Eerdere bekende functies van David H. Peyton
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DesignMedix, Inc.
![]() DesignMedix, Inc. Pharmaceuticals: MajorHealth Technology DesignMedix, Inc. develops drugs to overcome drug-resistant diseases. Its pipeline includes RCQ anti-malaria drugs, modified acridone and anti-bacterial drugs. The firm is a drug development company, which develops drugs to overcome drug resistance with a focus on curing malaria in Oregon. It develops drugs to address the large medical need caused by the rapid rise in drug resistance in multiple diseases. The company was founded by Sandra Lee Shotwell, David H. Peyton and Lynnor B. Stevenson in 2006 and is headquartered in Portland, OR. | Directeur/Bestuurslid | - | - |
Hoofd Techniek/Wetenschap/O&O | - | - | |
Oprichter | 01-01-2006 | - |
Opleiding van David H. Peyton
Abilene Christian University | Undergraduate Degree |
University of California, Santa Barbara | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoraal
Consumer Services | 4 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
DesignMedix, Inc.
![]() DesignMedix, Inc. Pharmaceuticals: MajorHealth Technology DesignMedix, Inc. develops drugs to overcome drug-resistant diseases. Its pipeline includes RCQ anti-malaria drugs, modified acridone and anti-bacterial drugs. The firm is a drug development company, which develops drugs to overcome drug resistance with a focus on curing malaria in Oregon. It develops drugs to address the large medical need caused by the rapid rise in drug resistance in multiple diseases. The company was founded by Sandra Lee Shotwell, David H. Peyton and Lynnor B. Stevenson in 2006 and is headquartered in Portland, OR. | Health Technology |
- Beurs
- Insiders
- David H. Peyton
- Ervaring